RGEN Q2 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$159M-23.3% YoY

Gross Profit

$80M50.2% margin

Operating Income

$19M12.1% margin

Net Income

$20M12.4% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

-3.8%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$578M

Stockholders' Equity

$2.0B

Cash & Equivalents

$604M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$159M	$208M	-23.3%
Gross Profit	$80M	$121M	-34.2%
Operating Income	$19M	$63M	-69.5%
Net Income	$20M	$50M	-60.3%

Revenue Segments

Product

$159M100%

Royalty

$36,0000%